GeVIR Banner

Export Results to CSV Clear Search

Genes Fold Enrichment Color Codes
  • Gene Name, Canonical Transcript - gene identifiers from gnomAD database (Build 37)
  • GeVIR % - gene rank measured in percentiles based on Gene Variation Intolerance Ranking (GeVIR) (low values indicate more variation intolerant genes, which is also true for "LOEUF %" and "VIRLoF %"). GeVIR is a method which we developed and applied on a list of 19,361 genes to sort them based on number, length and evolutionary conservation of regions without functional variants (i.e. between two missense, loss-of-function, insertion or delition variants) in gnomAD database (version 2.0.1). Only canonical transcripts were analysed.
  • LOEUF % - gene rank measured in percentiles based gnomAD loss-of-function observed/expected upper bound fraction (LOEUF) (see Figure 1). For more information about this metric, please read "Constraint" section of MacArthur Lab blog post. If you use this metric please cite gnomAD flagship paper and use most up-to-date values from gnomAD website.

    LoF observed/expected (o/e) upper Confidence Interval (CI)

    Figure 1. Screenshot of ELN gene constraint metrics from gnomAD browser

  • VIRLoF % - gene rank measured in percentiles based on both GeVIR and gnomAD LOEUF (shows the best overall performance, see Figure 2). If you use this metric please cite both GeVIR and gnomAD flagship paper.
  • GeVIR AD, LOEUF AD, VIRLoF AD, GeVIR AR, LOEUF AR, VIRLoF AR - to help users interpret gene ranks, we calculated fold enrichment of Autosomal Dominant (AD) and Autosomal Recessive (AR) genes with known molecular basis of disorder in OMIM in a range of +-5% of gene X (see Figure 2). Statistical significant fold enrichements (Fisher Exact Test p-value < 1e-5) are shown in bold in the table. For example CDK19 gene's GeVIR % is 2.37, so examined range is from 0 (2.37-5, rounded to minimal percentile) to 7.37% (2.37+5). Genes in this range are ~4 times more often (4.05 fold enrichement) associated with AD diseases and ~4 times less often (0.25 fold enrichement) associated with AR diseases. Both enrichment of AD genes and deficiency of AR genes is statistical significant. Thus GeVIR metric adds supportive evidence that CDK19 is more likely to be associated with AD than AR disease.

    Gene Percentiles AD AR Fold Enrichment

    Figure 2. Fold Enrichment of known Autosomal Dominant (AD) and Autosomal Recessive (AR) genes of each gene in the ranked lists (GeVIR, LOEUF, VIRLoF. AD genes are enriched among top ranked genes (lowest percentiles), whereas AR genes are enriched among middle ranked genes (approximetly 35-65 percentiles). Combined metric (VIRLoF, purple) shows the best perfornance, i.e. high ranked genes are more often associated with AD than AR diseases, low ranked genes are less often associated with both AD and AR diseases.
Gene Name Canonical Transcript GeVIR % LOEUF % VIRLoF % GeVIR AD LOEUF AD VIRLoF AD GeVIR AR LOEUF AR VIRLoF AR
RNASE8 ENST00000308227 84.97 97.68 94.10 0.28 0.21 0.09 0.46 0.19 0.12
C9orf37 ENST00000371417 96.78 98.29 99.30 0.11 0.21 0.11 0.11 0.15 0.04
H3F3C ENST00000340398 87.61 97.67 95.43 0.23 0.21 0.08 0.37 0.19 0.11
AC079341.1 ENST00000424958 91.18 98.28 97.65 0.15 0.21 0.09 0.21 0.15 0.06
OR2M2 ENST00000359682 98.95 97.67 99.62 0.10 0.21 0.12 0.11 0.19 0.04
OR5D16 ENST00000378396 86.54 98.27 95.25 0.25 0.21 0.08 0.41 0.15 0.10
MAGEB10 ENST00000356790 83.88 97.66 93.57 0.29 0.21 0.13 0.49 0.19 0.15
AL353698.1 ENST00000433279 91.17 98.27 97.62 0.15 0.21 0.09 0.21 0.15 0.06
AC016586.1 ENST00000535853 89.87 97.66 96.65 0.16 0.21 0.08 0.28 0.19 0.08
TMEM133 ENST00000303130 88.79 98.26 96.35 0.19 0.21 0.07 0.33 0.15 0.09
TPRXL ENST00000424053 89.87 97.65 96.64 0.16 0.21 0.08 0.28 0.19 0.08
DHRS4-AS1 ENST00000354854 91.16 98.26 96.95 0.15 0.21 0.08 0.21 0.15 0.07
C6orf120 ENST00000332290 95.70 97.64 98.74 0.11 0.21 0.10 0.12 0.19 0.05
AC092811.1 ENST00000366845 91.15 98.25 97.61 0.15 0.21 0.09 0.21 0.15 0.06
SLC35G5 ENST00000382435 88.20 97.64 95.72 0.20 0.21 0.07 0.34 0.19 0.11
OR4A15 ENST00000314706 94.86 98.25 98.72 0.10 0.21 0.10 0.11 0.15 0.05
MTRNR2L5 ENST00000512524 91.07 98.24 97.54 0.16 0.21 0.08 0.21 0.15 0.07
AF131215.5 ENST00000400102 91.06 98.24 98.42 0.16 0.21 0.10 0.21 0.15 0.05
AC019294.1 ENST00000543887 91.01 98.23 97.54 0.16 0.21 0.08 0.21 0.15 0.07
RP11-382J12.1 ENST00000499227 90.99 98.23 97.52 0.16 0.21 0.08 0.21 0.15 0.07
VN1R1 ENST00000321039 99.87 98.22 99.90 0.12 0.21 0.12 0.14 0.15 0.04
CRIPAK ENST00000324803 95.70 98.22 99.00 0.11 0.21 0.11 0.12 0.15 0.04
FLJ45079 ENST00000374983 98.97 98.21 99.77 0.10 0.21 0.12 0.12 0.15 0.04
CEMP1 ENST00000382350 97.80 98.21 99.54 0.11 0.20 0.12 0.11 0.15 0.05
AC025278.1 ENST00000377296 90.95 98.20 97.08 0.16 0.20 0.08 0.21 0.15 0.07

Cookies disclaimer

I agree Our site saves small pieces of text information (cookies) on your device in order to deliver better content and for statistical purposes. You can disable the usage of cookies by changing the settings of your browser. By browsing our website without changing the browser settings you grant us permission to store that information on your device.